Company Search:
Advanced Search
Sponsored Links
Kang Stem Biotech Co Ltd Company Snapshot
Kang Stem Biotech Co Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Kang Stem Biotech Co Ltd with three other miscellaneous service companies in Asia: CellSeed Incorporation of Japan (2016 sales of 100.67 million Japanese Yen [US$911,090.65 ] of which 50% was Regenerative Medicine Business Support), Healios Kk of Japan (77.64 million Japanese Yen [US$702,642.00 ] of which 100% was Pharmaceuticals Preparation), and Phytohealth Corp which is based in Taiwan (25.02 million Taiwanese Dollars [US$846,710.64 ] of which 60% was Drug).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Kang Stem Biotech Co Ltd
  Stock Performance Chart for Kang Stem Biotech Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 13,400
(Figures in Korean Won)
1 Week 5.1%   13 Weeks 16.5%  
4 Weeks 37.0%   52 Weeks 24.1%  
Kang Stem Biotech Co Ltd Key Data:
  Ticker: 217730 Country: Korea (South)
  Exchanges: SEO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 842,804,638
(Year Ending Jan 2017).
Employees: 62
  Currency: Korean Won Market Cap: 194,355,007,000
  Fiscal Yr Ends: December Shares Outstanding: 14,504,105
  Share Type: Korea Closely Held Shares: 4,912,882
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.